Golexanolone

Add links
Source: Wikipedia, the free encyclopedia.
Golexanolone
Clinical data
Other namesGR-3027; 3α-Ethynyl-3β-hydroxyandrostan-17E-one oxime
Identifiers
  • (3S,5S,8R,9S,10S,13S,14S,17E)-3-Ethynyl-17-hydroxyimino-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
JSmol)
  • C[C@]12CC[C@](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]\4([C@H]3CC/C4=N\O)C)(C#C)O
  • InChI=1S/C21H31NO2/c1-4-21(23)12-11-19(2)14(13-21)5-6-15-16-7-8-18(22-24)20(16,3)10-9-17(15)19/h1,14-17,23-24H,5-13H2,2-3H3/b22-18+/t14-,15-,16-,17-,19-,20-,21-/m0/s1
  • Key:FFIBGVYTWNPLPN-BZLGYYABSA-N

Golexanolone, also known by the developmental code name GR-3027, is a

γ-aminobutyric acid (GABA).[2]

See also

References

  1. ^ a b "Golexanolone - Umecrine Cognition". AdisInsight. Springer Nature Switzerland AG.
  2. ^
    S2CID 42040436
    .
  3. PMID 29492615
    .
  4. PMID 26138462
    .

External links
Retrieved from "https://en.wikipedia.org/w/index.php?title=Golexanolone&oldid=1123037779"